Tag Archives: NASDAQ:SGMO

A Director at Sangamo Biosciences (NASDAQ: SGMO) is Buying Shares

Yesterday, a Director at Sangamo Biosciences (SGMO – Research Report), Stewart Parker, bought shares of SGMO for $15.57K. Following this transaction Stewart Parker’s holding in the company was increased by 30% to a total of $72.28K. In addition to Stewart

Cowen & Co. Maintains Their Buy Rating on Sangamo Biosciences (SGMO)

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today. The company’s shares closed last Monday at $8.32. According to TipRanks.com, Baral is a 5-star analyst with an average return of 17.7%

H.C. Wainwright Reaffirms Their Buy Rating on Sangamo Biosciences (SGMO)

H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Sangamo Biosciences (SGMO – Research Report) today and set a price target of $16.00. The company’s shares closed last Monday at $8.53. According to TipRanks.com, Chattopadhyay is a 3-star analyst

H.C. Wainwright Keeps a Buy Rating on Sangamo Biosciences (SGMO)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on Sangamo Biosciences (SGMO – Research Report), with a price target of $16.00. The company’s shares closed last Monday at $8.42. According to TipRanks.com, Chattopadhyay is

Sangamo Biosciences (SGMO) Receives a Rating Update from a Top Analyst

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today. The company’s shares closed last Monday at $11.66. According to TipRanks.com, Baral is a top 100 analyst with an average return of

Sangamo Biosciences (SGMO) Gets a Hold Rating from Wedbush

In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Sangamo Biosciences (SGMO – Research Report), with a price target of $11.00. The company’s shares closed last Monday at $9.75. According to TipRanks.com, Moussatos has currently